KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target.
Wei Y, Ren X, Galbo PM Jr, Moerdler S, Wang H, Sica RA, Etemad-Gilbertson B, Shi L, Zhu L, Tang X, Lin Q, Peng M, Guan F, Zheng D, Chinai JM, Zang X.
Wei Y, et al. Among authors: zheng d.
Sci Immunol. 2021 Jul 9;6(61):eabf9792. doi: 10.1126/sciimmunol.abf9792.
Sci Immunol. 2021.
PMID: 34244312
Free PMC article.